FRI183 Phase 4 Study Of Hypercortisolism In Patients With Difficult-to-Control Type 2 Diabetes Despite Receiving Standard-of-Care Therapies: Prevalence And Treatment With Mifepristone

Disclosure: J.P. Frias: Advisory Board Member; Self; Corcept Therapeutics. Consulting Fee; Self; Corcept Therapeutics. Other; Self; Corcept Therapeutics. R.J. Auchus: Consulting Fee; Self; Corcept Therapeutics. Grant Recipient; Self; Corcept Therapeutics. Speaker; Self; Corcept Therapeutics. Other;...

Descripción completa

Detalles Bibliográficos
Autores principales: Frias, Juan Pablo, Auchus, Richard Joseph, Bancos, Irina, Blonde, Lawrence, Busch, Robert S, Buse, John B, DeFronzo, Ralph Anthony, Findling, James W, Fonseca, Vivian, Hamidi, Oksana, Handelsman, Yehuda, Pratley, Richard E, Rosenstock, Julio, Tudor, Iulia Cristina, Moraitis, Andreas G, Einhorn, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Adrenal (Excluding Mineralocorticoids)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554436/
http://dx.doi.org/10.1210/jendso/bvad114.178

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554436/
http://dx.doi.org/10.1210/jendso/bvad114.178

Ejemplares similares